Detailed studies on the antitumor effects of GAL agonists or antagonists have yet to be conducted in many types of cancer; thus, to obtain a detailed understanding of the different distribution patterns of GALRs and the different signaling pathways involved in tumor cells will help to identify the antiproliferative or proliferative actions played by these receptors and to develop new antitumor strategies. Here, GAL is linked to cancer.